JFNCX
Price
$62.27
Change
+$0.40 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
JFNIX
Price
$74.71
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
Interact to see
Advertisement

JFNCX vs JFNIX

Header iconJFNCX vs JFNIX Comparison
Open Charts JFNCX vs JFNIXBanner chart's image
Janus Henderson Global Life Sciences C
Price$62.27
Change+$0.40 (+0.65%)
VolumeN/A
Net Assets4.49B
Janus Henderson Global Life Sciences I
Price$74.71
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
JFNCX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
JFNCX vs. JFNIX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNCX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNCX (4.49B) and JFNIX (4.49B) have equal amount of cash in the bank . JFNIX pays higher dividends than JFNCX: JFNIX (0.38) vs JFNCX (0.00). JFNCX was incepted earlier than JFNIX: JFNCX (16 years) vs JFNIX (16 years). JFNCX (1.76) is less costly to investors than JFNIX (0.77). JFNCX (35.00) and JFNIX (35.00) have comparable annual turnover. JFNCX (2500) and JFNIX (2500) have matching initial minimum investment requirements. JFNIX annual gain was more profitable for investors over the last year : -6.30 vs. JFNCX (-8.04). JFNIX return over 5 years is better than : 8.06 vs. JFNCX (-0.63).
JFNCXJFNIXJFNCX / JFNIX
Total Expense Ratio1.760.77229%
Annual Report Gross Expense Ratio1.760.77229%
Fund Existence16 years16 years-
Gain YTD8.3359.13091%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B4.49B100%
Annual Yield % from dividends0.000.38-
Returns for 1 year-8.04-6.30128%
Returns for 3 years18.8024.2977%
Returns for 5 years-0.638.06-8%
Returns for 10 years20.1841.0449%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEQYX20.230.06
+0.30%
Putnam Focused International Equity Y
AHSCX12.45N/A
N/A
Alger Health Sciences C
RRCOX65.34N/A
N/A
T. Rowe Price U.S. Equity Research R
VMIDX25.46N/A
N/A
VALIC Company I Mid Cap Index
MEFIX16.20N/A
N/A
ClearBridge Emerging Markets FI